AGP Picks
View all

California News Observer: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on California News Observer.

Press releases published on September 28, 2026

Palisade Bio to Present Clinical and Translational Data for PALI-2108 in Ulcerative Colitis and Crohn’s Disease at UEG Week 2026
Wedbush Expands Market Access with Launch of FutureSports Performance Index Products
Carlsmed Appoints Richard Heppenstall as Chief Financial Officer
Dare Bioscience Announces New U.S. Patent Strengthening DARE-HPV Program as a Potential First FDA-Approved Pharmacologic Treatment for HPV Infection
Adhesion Wealth Launches Custom Model Solutions for RIAs
NETSOL Technologies reports record fiscal 2026 revenue and full-year profitability, exceeding guidance
4DMT Advances 4D-150 into Phase 3 for Second Large Market Retina Indication with Initiation of 4SIGHT in DME
Route 92 Medical Announces U.S. FDA Clearance for the FreeClimb® 46 Catheter with Tenzing® 4
ALX Oncology Announces Nature Medicine Publication of ASPEN-06 Phase 2 Clinical Data Demonstrating Strong Responses and Durable Clinical Benefit with Evorpacept in HER2-Positive Gastric Cancer
NeOnc Technologies Announces FDA End of Phase 1 Meeting for NEO212
Aemetis Receives $22.4 million from Sale of Section 45Z Clean Fuel Production Tax Credits
FRIDAY PNR INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Files Class Action Lawsuit against Pentair plc and Announces Opportunity for Investors with Substantial Losses to Lead Class Action Lawsuit
1 WEEK BABA INVESTOR DEADLINE: Alibaba Group Holding Limited Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit before October 5, 2026 Deadline, Robbins Geller Rudman & Dowd LLP Announces
VisionWave Highlights STRATUM Autonomous Ground Systems Platform for Multi-Mission Defense Operations
BlossomHill Therapeutics Presents Preclinical Data on Novel Pan-KRAS Inhibitor, BH-501284, at the AACR Conference on Pancreatic Cancer
Sagimet Biosciences to Host Virtual KOL Event, “Denifanstat Update: 52-Week Data from Phase 3 Open-Label Extension in China and Planned AURORA Phase 3 Clinical Trial in US” on September 30, 2026
NVIDIA Announces a $150 Billion Share Repurchase Authorization Increase
Armlogi Holding Corp. Reports Fiscal Year 2026 Financial Results; Warehousing Services Revenue Grows 21.9% to $77.1 Million
MediciNova Announces Topline Results from  MN-001-NATG-202 Clinical Trial of MN-001 (Tipelukast)
Codexis Enters into an Agreement with Pioneering siRNA Drug Innovator to Leverage the ECO Synthesis Manufacturing Platform to Create Stereo-defined siRNA

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

California News Observer

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.